Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Rothmund-Thomson syndrome and osteoma cutis in a patient previously diagnosed as COPS syndrome.

van Rij MC, Grijsen ML, Appelman-Dijkstra NM, Hansson KB, Ruivenkamp CA, Mulder K, van Doorn R, Oranje AP, Kant SG.

Eur J Pediatr. 2017 Feb;176(2):279-283. doi: 10.1007/s00431-016-2834-3. Epub 2016 Dec 30.

2.

Quality of life measurement in atopic dermatitis. Position paper of the European Academy of Dermatology and Venereology (EADV) Task Force on quality of life.

Chernyshov PV, Tomas-Aragones L, Manolache L, Marron SE, Salek MS, Poot F, Oranje AP, Finlay AY; EADV Quality of Life Task Force.

J Eur Acad Dermatol Venereol. 2017 Apr;31(4):576-593. doi: 10.1111/jdv.14058. Epub 2017 Jan 17. Review.

PMID:
27879008
3.

Current and future treatments of alopecia areata and trichotillomania in children.

Iorizzo M, Oranje AP.

Expert Opin Pharmacother. 2016 Sep;17(13):1767-73. doi: 10.1080/14656566.2016.1217990. Epub 2016 Aug 9. Review.

PMID:
27484130
4.

Mastocytosis: a comprehensive insight.

VAN Gysel D, DE Maeseneer H, Oranje AP.

G Ital Dermatol Venereol. 2016 Aug;151(4):385-96. Epub 2016 Apr 12. Review.

PMID:
27070304
5.

Scoring systems for infantile hemangioma: the Hemangioma Activity Score versus the Hemangioma Activity and Severity Index.

Janmohamed SR, Oranje AP.

Int J Dermatol. 2016 Jul;55(7):e416-7. doi: 10.1111/ijd.13242. Epub 2016 Feb 12. No abstract available.

PMID:
26872855
6.

Propranolol in the treatment of infantile haemangiomas: lessons from the European Propranolol In the Treatment of Complicated Haemangiomas (PITCH) Taskforce survey.

Wedgeworth E, Glover M, Irvine AD, Neri I, Baselga E, Clayton TH, Beattie PE, Bjerre JV, Burrows NP, Foelster-Holst R, Hedelund L, Hernandez-Martin A, Audrain H, Bhate K, Brown SJ, Baryschpolec S, Darne S, Durack A, Dvorakova V, Gach J, Goldstraw N, Goodyear H, Grabczynska S, Greenblatt D, Halpern J, Hearn RM, Hoey S, Hughes B, Jayaraj R, Johansson EK, Lam M, Leech S, O'Regan GM, Morrison D, Porter W, Ramesh R, Schill T, Shaw L, Taylor AE, Taylor R, Thomson J, Tiffin P, Tsakok M, Janmohamed SR, Laguda B, McPherson T, Oranje AP, Patrizi A, Ravenscroft JC, Shahidullah H, Solman L, Svensson A, Wahlgren CF, Hoeger PH, Flohr C.

Br J Dermatol. 2016 Mar;174(3):594-601. doi: 10.1111/bjd.14233. Epub 2015 Dec 26.

PMID:
26473312
7.

EAACI position paper for practical patch testing in allergic contact dermatitis in children.

de Waard-van der Spek FB, Darsow U, Mortz CG, Orton D, Worm M, Muraro A, Schmid-Grendelmeier P, Grimalt R, Spiewak R, Rudzeviciene O, Flohr C, Halken S, Fiocchi A, Borrego LM, Oranje AP.

Pediatr Allergy Immunol. 2015 Nov;26(7):598-606. doi: 10.1111/pai.12463.

PMID:
26287570
8.

Scoring the therapeutic effects of oral propranolol for infantile hemangioma: A prospective study comparing the Hemangioma Activity Score (HAS) with the Hemangioma Severity Scale (HSS).

Janmohamed SR, van Oosterhout M, de Laat PC, van Rosmalen J, Madern GC, Oranje AP.

J Am Acad Dermatol. 2015 Aug;73(2):258-63. doi: 10.1016/j.jaad.2015.05.012.

PMID:
26183969
9.

Treatment of infantile haemangiomas: recommendations of a European expert group.

Hoeger PH, Harper JI, Baselga E, Bonnet D, Boon LM, Ciofi Degli Atti M, El Hachem M, Oranje AP, Rubin AT, Weibel L, Léauté-Labrèze C.

Eur J Pediatr. 2015 Jul;174(7):855-65. doi: 10.1007/s00431-015-2570-0. Epub 2015 May 29. Review.

PMID:
26021855
10.

Recent developments in the management of common childhood skin infections.

Oranje AP, de Waard-van der Spek FB.

J Infect. 2015 Jun;71 Suppl 1:S76-9. doi: 10.1016/j.jinf.2015.04.030. Epub 2015 Apr 29. Review.

PMID:
25936745
11.

Trichotillomania in Children.

Chandran NS, Novak J, Iorizzo M, Grimalt R, Oranje AP.

Skin Appendage Disord. 2015 Mar;1(1):18-24. doi: 10.1159/000371809. Epub 2015 Feb 5.

12.

Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis.

van Oosterhout M, Janmohamed SR, Spierings M, Hiddinga J, de Waard-van der Spek FB, Oranje AP.

Dermatology. 2015;230(2):105-12. doi: 10.1159/000367689. Epub 2015 Jan 31.

PMID:
25660989
13.

Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.

Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U.

Pediatr Allergy Immunol. 2015 Jun;26(4):306-15. doi: 10.1111/pai.12331. Epub 2015 Apr 13. Review.

14.

Support for the hypoxia theory in the pathogenesis of infantile haemangioma.

Janmohamed SR, Brinkhuizen T, den Hollander JC, Madern GC, de Laat PC, van Steensel MA, Oranje AP.

Clin Exp Dermatol. 2015 Jun;40(4):431-7. doi: 10.1111/ced.12557. Epub 2014 Dec 16.

PMID:
25511669
15.

The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia.

Boersma IH, Oranje AP, Grimalt R, Iorizzo M, Piraccini BM, Verdonschot EH.

Indian J Dermatol Venereol Leprol. 2014 Nov-Dec;80(6):521-5. doi: 10.4103/0378-6323.144162.

16.

Educational paper: therapy of infantile haemangioma--history and current state (part II).

Janmohamed SR, Madern GC, de Laat PC, Oranje AP.

Eur J Pediatr. 2015 Feb;174(2):259-66. doi: 10.1007/s00431-014-2404-5. Epub 2014 Sep 3. Review.

PMID:
25178895
17.

Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Janmohamed SR, Madern GC, de Laat PC, Oranje AP.

Eur J Pediatr. 2015 Jan;174(1):97-103. doi: 10.1007/s00431-014-2403-6. Epub 2014 Aug 26. Review.

PMID:
25156689
18.

A statistical model to predict the reduction of lichenification in atopic dermatitis.

Glazenburg EJ, Mulder PG, Oranje AP.

Acta Derm Venereol. 2015 Mar;95(3):294-7. doi: 10.2340/00015555-1881.

19.

Intractable vascular autonomic dysregulation (Harlequin phenomenon) in two brothers: another indication for propranolol?

Janmohamed SR, Madern GC, de Laat PC, Oranje AP; Workgroup on Vascular Abnormalities Rotterdam.

Dermatol Ther. 2014 Jul-Aug;27(4):230-2. doi: 10.1111/dth.12124. Epub 2014 Apr 17.

PMID:
24750208
20.

Evidence - based pharmacological treatment of atopic dermatitis: an expert opinion and new expectations.

Oranje AP.

Indian J Dermatol. 2014 Mar;59(2):140-2. doi: 10.4103/0019-5154.127673.

21.

The proactive wet-wrap method with diluted corticosteroids versus emollients in children with atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled trial.

Janmohamed SR, Oranje AP, Devillers AC, Rizopoulos D, van Praag MC, Van Gysel D, Goeteyn M, de Waard-van der Spek FB.

J Am Acad Dermatol. 2014 Jun;70(6):1076-82. doi: 10.1016/j.jaad.2014.01.898. Epub 2014 Mar 31.

PMID:
24698702
22.

Minoxidil 5% solution for topical treatment of loose anagen hair syndrome.

Chandran NS, Oranje AP.

Pediatr Dermatol. 2014 May-Jun;31(3):389-90. doi: 10.1111/pde.12307. Epub 2014 Mar 6.

PMID:
24602086
23.

The European TREatment of severe Atopic eczema in children Taskforce (TREAT) survey.

Proudfoot LE, Powell AM, Ayis S, Barbarot S, Baselga Torres E, Deleuran M, Fölster-Holst R, Gelmetti C, Hernández-Martin A, Middelkamp-Hup MA, Oranje AP, Logan K, Perkin M, Patrizi A, Rovatti G, Schofield O, Spuls P, Svensson Å, Vestergaard C, Wahlgren CF, Schmitt J, Flohr C; European Dermato-Epidemiology Network (EDEN).

Br J Dermatol. 2013 Oct;169(4):901-9. doi: 10.1111/bjd.12505. Erratum in: Br J Dermatol. 2013 Nov;169(5):1171. Perkins, M [corrected to Perkin, M].

PMID:
23855450
24.

Educational paper: parenting a child with a disfiguring condition-how (well) do parents adapt?

Leemreis WH, Okkerse JM, de Laat PC, Madern GC, van Adrichem LN, Verhulst F, Oranje AP.

Eur J Pediatr. 2014 Jun;173(6):699-709. doi: 10.1007/s00431-013-2061-0. Epub 2013 Jun 18. Review.

PMID:
23775538
25.

Multiple cutaneous infantile haemangiomas and the risk of internal haemangioma.

Vredenborg AD, Janmohamed SR, de Laat PC, Madern GC, Oranje AP.

Br J Dermatol. 2013 Jul;169(1):188-91. doi: 10.1111/bjd.12229. No abstract available.

PMID:
23421718
26.

Educational paper: neonatal skin lesions.

Hulsmann AR, Oranje AP.

Eur J Pediatr. 2014 May;173(5):557-66. doi: 10.1007/s00431-013-1956-0. Epub 2013 Feb 6. Review.

PMID:
23385854
27.

Allergic contact dermatitis in children: which factors are relevant? (review of the literature).

de Waard-van der Spek FB, Andersen KE, Darsow U, Mortz CG, Orton D, Worm M, Muraro A, Schmid-Grendelmeier P, Grimalt R, Spiewak R, Rudzeviciene O, Flohr C, Halken S, Fiocchi A, Borrego LM, Oranje AP.

Pediatr Allergy Immunol. 2013 Jun;24(4):321-9. doi: 10.1111/pai.12043. Epub 2013 Feb 3. Review.

PMID:
23373713
28.

Scoring the proliferative activity of haemangioma of infancy: to HAS or not to HAS? Reply from author.

Janmohamed SR, de Waard-van der Spek FB, Madern GC, de Laat PC, Hop WC, Oranje AP.

Clin Exp Dermatol. 2013 Jan;38(1):90-1. doi: 10.1111/ced.12056. No abstract available.

PMID:
23252756
29.

Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.

Nieuwenhuis K, de Laat PC, Janmohamed SR, Madern GC, Oranje AP.

Pediatr Dermatol. 2013 Jan-Feb;30(1):64-70. doi: 10.1111/j.1525-1470.2012.01846.x. Epub 2012 Sep 7.

PMID:
22958179
30.

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum; European Academy of Dermatology and Venereology; European Task Force on Atopic Dermatitis; European Federation of Allergy; European Society of Pediatric Dermatology; Global Allergy and Asthma European Network.

J Eur Acad Dermatol Venereol. 2012 Sep;26(9):1176-93. doi: 10.1111/j.1468-3083.2012.04636.x. Epub 2012 Jul 19. Review.

PMID:
22813359
31.

Guidelines for treatment of atopic eczema (atopic dermatitis) part I.

Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schäfer T, Schwennesen T, Seidenari S, Simon D, Ständer S, Stingl G, Szalai S, Szepietowski JC, Taïeb A, Werfel T, Wollenberg A, Darsow U; European Dermatology Forum (EDF); European Academy of Dermatology and Venereology (EADV); European Federation of Allergy (EFA); European Task Force on Atopic Dermatitis (ETFAD); European Society of Pediatric Dermatology (ESPD); Global Allergy and Asthma European Network (GA2LEN).

J Eur Acad Dermatol Venereol. 2012 Aug;26(8):1045-60. doi: 10.1111/j.1468-3083.2012.04635.x.

PMID:
22805051
32.

Treating hemangioma of infancy with beta-blockers: is there really a risk of hypotension?

Janmohamed SR, de Laat PC, Madern GC, Dorresteijn EM, Jan Danser AH, Oranje AP.

J Am Acad Dermatol. 2012 Aug;67(2):315-6; author reply 316-8. doi: 10.1016/j.jaad.2012.01.046. No abstract available.

PMID:
22794806
33.

Wet-wrap treatment in children with atopic dermatitis: a practical guideline.

Devillers AC, Oranje AP.

Pediatr Dermatol. 2012 Jan-Feb;29(1):24-7. doi: 10.1111/j.1525-1470.2011.01691.x. Review.

PMID:
22256990
34.

Evaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.

Janmohamed SR, Madern GC, Nieuwenhuis K, de Laat PC, Oranje AP.

Pediatr Surg Int. 2012 Apr;28(4):393-8. doi: 10.1007/s00383-011-3037-7. Epub 2011 Dec 27.

35.

Treatment of small superficial haemangioma with timolol 0.5% ophthalmic solution: a series of 20 cases.

Oranje AP, Janmohamed SR, Madern GC, de Laat PC.

Dermatology. 2011;223(4):330-4. doi: 10.1159/000334778. Epub 2011 Dec 16.

PMID:
22179543
36.

Scoring the proliferative activity of haemangioma of infancy: the Haemangioma Activity Score (HAS).

Janmohamed SR, de Waard-van der Spek FB, Madern GC, de Laat PC, Hop WC, Oranje AP.

Clin Exp Dermatol. 2011 Oct;36(7):715-23. doi: 10.1111/j.1365-2230.2011.04080.x. Epub 2011 Jun 10.

PMID:
21933230
37.

Haemangioma of infancy: two case reports with an overdose of propranolol.

Janmohamed SR, Madern GC, de Laat PC, Oranje AP.

Case Rep Dermatol. 2011 Jan;3(1):18-21. doi: 10.1159/000324421. Epub 2011 Feb 5.

38.

Do we have to check glucose in patients with haemangioma of infancy treated with beta-blockers?

Janmohamed SR, de Laat PC, Madern GC, Oranje AP.

J Eur Acad Dermatol Venereol. 2011 Dec;25(12):1490. doi: 10.1111/j.1468-3083.2011.04191.x. Epub 2011 Jul 29. No abstract available.

PMID:
21797931
39.
40.

Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice.

van Valburg RW, Willemsen MG, Dirven-Meijer PC, Oranje AP, van der Wouden JC, Moed H.

Acta Derm Venereol. 2011 Mar;91(2):147-51. doi: 10.2340/00015555-1026.

41.

Use of skin substitute dressings in the treatment of staphylococcal scalded skin syndrome in neonates and young infants.

Baartmans MG, Dokter J, den Hollander JC, Kroon AA, Oranje AP.

Neonatology. 2011;100(1):9-13. doi: 10.1159/000317997. Epub 2010 Dec 9.

PMID:
21150225
42.

Management of urticaria and angioedema in children: new trends.

Oranje AP.

G Ital Dermatol Venereol. 2010 Dec;145(6):771-4.

PMID:
21139553
43.

Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?

Otten MH, Prince FH, Ten Cate R, van Rossum MA, Twilt M, Hoppenreijs EP, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LW.

Ann Rheum Dis. 2011 Feb;70(2):337-40. doi: 10.1136/ard.2010.135731. Epub 2010 Nov 10.

PMID:
21068101
44.

Rhabdoid tumor mimicking hemangioma.

Assen YJ, Madern GC, de Laat PC, den Hollander JC, Oranje AP.

Pediatr Dermatol. 2011 May-Jun;28(3):295-8. doi: 10.1111/j.1525-1470.2010.01248.x. Epub 2010 Sep 1.

PMID:
20825569
45.

Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).

Gooskens SL, Oranje AP, van Adrichem LN, de Waard-van der Spek FB, den Hollander JC, van de Ven CP, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2010 Aug;55(2):369-73. doi: 10.1002/pbc.22494. Review.

PMID:
20582941
46.

[Atopic eczema in children: a prospective study into prevalence and severity].

Dirven-Meijer PC, Glazenburg EJ, Mulder PG, Oranje AP.

Ned Tijdschr Geneeskd. 2009;153:B404. Dutch.

PMID:
19857309
47.

Clinical aspects of diffuse cutaneous mastocytosis in children: two variants.

Heide R, Zuidema E, Beishuizen A, Den Hollander JC, Van Gysel D, Seyger MM, Pasmans SG, Kakourou T, Oranje AP.

Dermatology. 2009;219(4):309-15. doi: 10.1159/000243808. Epub 2009 Oct 1.

PMID:
19797893
48.

The prevalence, characteristics of and risk factors for eczema in Belgian schoolchildren.

Govaere E, Van Gysel D, Verhamme KM, Doli E, Oranje AP, De Baets F.

Pediatr Dermatol. 2009 Mar-Apr;26(2):129-38.

PMID:
19425274
49.

Determinants of regional differences in the incidence of impetigo.

Razmjou RG, Willemsen SP, Koning S, Oranje AP, Schellevis F, van der Wouden JC.

Environ Res. 2009 Jul;109(5):590-3. doi: 10.1016/j.envres.2009.03.003. Epub 2009 Apr 14.

PMID:
19368906
50.

The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron.

van Steensel MA, Oranje AP, van der Schroeff JG, Wagner A, van Geel M.

Am J Med Genet A. 2009 Feb 15;149A(4):657-61. doi: 10.1002/ajmg.a.32744.

PMID:
19291775

Supplemental Content

Loading ...
Support Center